Company / Revenue per Share
PLUS THERAPEUTICS, INC. Revenue per Share History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.99
FY2025
5-year range
$0.02 / $1.11
FY2021-FY2025
Trend
-10.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has fluctuated over the past 10 years, ranging from $0.02 in FY2017 to $1.11 in FY2024.
Based on SEC 10-K filings.
0.99 in FY2025 with a 10-year CAGR of +30.0%.
Improved from $0.47 to $0.99 over the past 7 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +30.0%
Key checks
Key Insights
- In FY2025, revenue per share decreased 10.7% year-over-year.
- Peak revenue per share was recorded in FY2024.
- Lowest revenue per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.99 | -10.7% |
| FY2024 | $1.11 | +137.7% |
| FY2018 | $0.47 | +1897.5% |
| FY2017 | $0.02 | -93.7% |
| FY2016 | $0.37 | +419.0% |
| FY2015 | $0.07 | -41.3% |
| FY2014 | $0.12 | +0.8% |
| FY2013 | $0.12 | -17.0% |
| FY2012 | $0.15 | +29.8% |
| FY2011 | $0.11 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026